牛牛AI助理已提取核心訊息
Scott T. Reents, an officer at AbbVie Inc., is set to sell 14,140 shares of the company's common stock on February 23, 2024. The shares, valued at approximately $2,509,130.78, were acquired on the same day through the exercise of stock options as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Reents in the past three months.
Scott T. Reents, an officer at AbbVie Inc., is set to sell 14,140 shares of the company's common stock on February 23, 2024. The shares, valued at approximately $2,509,130.78, were acquired on the same day through the exercise of stock options as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Reents in the past three months.
艾伯維公司高管斯科特·雷恩茨定於2024年2月23日出售該公司的14,140股普通股。這些股票價值約2,509,130.78美元，是當天通過行使股票期權收購的，這是發行人補償的一部分。此次交易是在過去三個月中Rents沒有報告任何重大銷售活動之後進行的。
艾伯維公司高管斯科特·雷恩茨定於2024年2月23日出售該公司的14,140股普通股。這些股票價值約2,509,130.78美元，是當天通過行使股票期權收購的，這是發行人補償的一部分。此次交易是在過去三個月中Rents沒有報告任何重大銷售活動之後進行的。
有用
沒用
